Literature DB >> 14512963

Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Meniere's disease.

Shin-ichi Usami1, Kentaro Takahashi, Isamu Yuge, Akihiro Ohtsuka, Atsushi Namba, Satoko Abe, Erik Fransen, Laszlo Patthy, Gottfried Otting, Guy Van Camp.   

Abstract

The COCH gene is the only gene identified in man that causes autosomal dominantly inherited hearing loss associated with vestibular dysfunction. The condition is rare and only five mutations have been reported worldwide. All affected families showed a similar progressive hearing loss and vestibular dysfunction. Since Meniere's disease-like symptoms have also been described in some families, it was suggested that COCH mutations might be present in some patients diagnosed with Meniere's disease. In this study, using a Japanese population, we performed a COCH mutation analysis in 23 patients from independent families with autosomal dominant hearing impairment, four of whom reported vestibular symptoms, and also in 20 Meniere's patients. While a new point mutation, A119 T, was found in a patient with autosomal dominant hearing loss and vestibular symptoms, no mutations were found in the Meniere's patients. Like all other previously identified COCH mutations, the mutation identified here is a missense mutation located in the FCH domain of the protein. The current mutation is located in close spatial proximity to W117, in which a mutation (W117R) had previously been associated with autosomal dominant hearing loss. Model building suggests that, like the W117R mutation, the A119 T mutation does not affect the structural integrity of the FCH domain, but may interfere with the interaction with a yet unknown binding partner. We conclude that mutations in the COCH gene are responsible for a significant fraction of patients with autosomal dominantly inherited hearing loss accompanied by vestibular symptoms, but not for dominant hearing loss without vestibular dysfunction, or sporadic Meniere's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512963     DOI: 10.1038/sj.ejhg.5201043

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  28 in total

1.  Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.

Authors:  Sherri M Jones; Nahid G Robertson; Shelly Given; Anne B S Giersch; M Charles Liberman; Cynthia C Morton
Journal:  Hear Res       Date:  2010-11-10       Impact factor: 3.208

2.  Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.

Authors:  Lang Li; Tammy Sajdyk; Ellen M L Smith; Chien Wei Chang; Claire Li; Richard H Ho; Raymond Hutchinson; Elizabeth Wells; Jodi L Skiles; Naomi Winick; Paul L Martin; Jamie L Renbarger
Journal:  Clin Pharmacol Ther       Date:  2019-01-21       Impact factor: 6.875

3.  Sequence variants in host cell factor C1 are associated with Ménière's disease.

Authors:  Jeffrey T Vrabec; Liqian Liu; Bingshan Li; Suzanne M Leal
Journal:  Otol Neurotol       Date:  2008-06       Impact factor: 2.311

Review 4.  Genetic disorders of the vestibular system.

Authors:  Robert W Eppsteiner; Richard J H Smith
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2011-10       Impact factor: 2.064

5.  Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.

Authors:  Georgios K Tsirves; Paraskevi V Voulgari; Eleftherios Pelechas; Asimakis D Asimakopoulos; Alexandros A Drosos
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-30       Impact factor: 2.503

Review 6.  Genes important for otoneurological diagnostic purposes - current status and future prospects.

Authors:  K Pawlak-Osiñska; K Linkowska; T Grzybowski
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

7.  Cochlin expression in vestibular endorgans obtained from patients with Meniere's disease.

Authors:  Audrey P Calzada; Ivan A Lopez; Luis Beltran Parrazal; Akira Ishiyama; Gail Ishiyama
Journal:  Cell Tissue Res       Date:  2012-09-20       Impact factor: 5.249

8.  Distinct vestibular phenotypes in DFNA9 families with COCH variants.

Authors:  Bong Jik Kim; Ah Reum Kim; Kyu-Hee Han; Yoon Chan Rah; Jaihwan Hyun; Brandon S Ra; Ja-Won Koo; Byung Yoon Choi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-13       Impact factor: 2.503

9.  The Polymorphic Analysis of the Human Potassium Channel KCNE Gene Family in Meniere's Disease-A Preliminary Study.

Authors:  Qingqing Dai; Dan Wang; Hong Zheng
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

10.  Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder.

Authors:  Tomoko Makishima; Clara I Rodriguez; Nahid G Robertson; Cynthia C Morton; Colin L Stewart; Andrew J Griffith
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.